HB4203 - 104th General Assembly (2025-2026)

INS CD-CANCER SCREENINGS
Last Action
4/28/2026 - Senate: Assigned to Insurance
Statutes Amended In Order of Appearance
215 ILCS 5/356u  
Synopsis As Introduced
Amends the Illinois Insurance Code. In a provision concerning coverage of certain cancer screenings, adds having a high level of CA-125, as indicated by a blood test screening, to the definition of "at risk for ovarian cancer". Provides that "surveillance tests for ovarian cancer" means all medically viable methods for the detection and diagnosis of ovarian cancer, including, but not limited to, ultrasounds, magnetic resonance imagings (MRIs), x-rays, computed tomography (CT) scans, and CA-125 blood test screenings (instead of an annual screening using (i) CA-125 serum tumor marker testing, (ii) transvaginal ultrasound, (iii) pelvic examination). Effective January 1, 2028.
Actions
DateChamberAction
11/14/2025HouseFiled with the Clerk by Rep. Norine K. Hammond
1/14/2026HouseFirst Reading
1/14/2026HouseReferred to Rules Committee
3/18/2026HouseAssigned to Insurance Committee
3/24/2026HouseDo Pass / Short Debate Insurance Committee; 015-000-000
3/25/2026HousePlaced on Calendar 2nd Reading - Short Debate
4/10/2026HouseSecond Reading - Short Debate
4/10/2026HouseHeld on Calendar Order of Second Reading - Short Debate
4/14/2026HouseAdded Co-Sponsor Rep. Janet Yang Rohr
4/14/2026HousePlaced on Calendar Order of 3rd Reading - Short Debate
4/14/2026HouseThird Reading - Short Debate - Passed 109-000-000
4/15/2026SenateArrive in Senate
4/15/2026SenatePlaced on Calendar Order of First Reading April 16, 2026
4/15/2026HouseAdded Co-Sponsor Rep. Jackie Haas
4/15/2026HouseAdded Co-Sponsor Rep. Tony M. McCombie
4/16/2026SenateChief Senate Sponsor Sen. Terri Bryant
4/16/2026SenateFirst Reading
4/16/2026SenateReferred to Assignments
4/28/2026SenateAssigned to Insurance